Fennec Pharmaceuticals In... (FENC)
NASDAQ: FENC
· Real-Time Price · USD
8.46
0.39 (4.83%)
At close: Jun 24, 2025, 3:59 PM
8.45
-0.12%
After-hours: Jun 24, 2025, 04:04 PM EDT
4.83% (1D)
| Bid | 8.12 |
| Market Cap | 233.65M |
| Revenue (ttm) | 30.91M |
| Net Income (ttm) | -14.07M |
| EPS (ttm) | -0.53 |
| PE Ratio (ttm) | -15.96 |
| Forward PE | 9.56 |
| Analyst | Strong Buy |
| Ask | 8.47 |
| Volume | 57,654 |
| Avg. Volume (20D) | 84,200 |
| Open | 8.21 |
| Previous Close | 8.07 |
| Day's Range | 8.14 - 8.47 |
| 52-Week Range | 3.96 - 8.72 |
| Beta | 0.40 |
About FENC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FENC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FENC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Fennec Pharmaceuticals Inc. is scheduled to release its earnings on Aug 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-11.19%
Fennec Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
7 months ago
-11.92%
Fennec Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 financial results.
1 month ago · seekingalpha.com
Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call TranscriptFennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Robert Andrade - Chief Financial Officer Jeff Hackman - Chief Executive Officer...
